Axelar AB   Report issue

For profit Phase 2
Founded: Solna Sweden (2003)
Status: Left NME R&D (2021)

Organization Overview

First Clinical Trial
2008
NCT01062620
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now